Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary T Brophy

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care SystemJennifer La, Tammy Hshieh, Anahid Hamparsumian, et al.
The New England Journal of Medicine|December 14, 2022
Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular EventsAreef Ishani, William C Cushman, Sarah M Leatherman, et al.
JAMA Network Open|June 12, 2023
Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care SystemKylee L Martens, Ang Li, Jennifer La, et al.
Patterns (New York, N.Y.)|November 18, 2020
The Veterans Affairs Precision Oncology Data Repository, a Clinical, Genomic, and Imaging Research DatabaseDanne C Elbers, Nathanael R Fillmore, Feng-Chi Sung, et al.
Cancers|July 2, 2021
Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare SystemClark DuMontier, Nathanael R Fillmore, Cenk Yildirim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 16, 2023
Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in GoutLindsay N Helget, James R O'Dell, Jeff A Newcomb, et al.
Pharmacoepidemiology and Drug Safety|December 2, 2022
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare SystemJennifer La, Clark DuMontier, Hamza Hassan, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancerJulie Tsu-Yu Wu, June Corrigan, Chloe Su, et al.
Cold Spring Harbor Molecular Case Studies|December 5, 2023
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data CommonsKyle M Hernandez, Aarti Venkat, Danne C Elbers, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancerJulie Tsu-Yu Wu, June Corrigan, Chloe Su, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care SystemJennifer La, Tammy Hshieh, Anahid Hamparsumian, et al.
The New England Journal of Medicine|December 14, 2022
Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular EventsAreef Ishani, William C Cushman, Sarah M Leatherman, et al.
JAMA Network Open|June 12, 2023
Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care SystemKylee L Martens, Ang Li, Jennifer La, et al.
Patterns (New York, N.Y.)|November 18, 2020
The Veterans Affairs Precision Oncology Data Repository, a Clinical, Genomic, and Imaging Research DatabaseDanne C Elbers, Nathanael R Fillmore, Feng-Chi Sung, et al.
Cancers|July 2, 2021
Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare SystemClark DuMontier, Nathanael R Fillmore, Cenk Yildirim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 16, 2023
Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in GoutLindsay N Helget, James R O'Dell, Jeff A Newcomb, et al.
Pharmacoepidemiology and Drug Safety|December 2, 2022
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare SystemJennifer La, Clark DuMontier, Hamza Hassan, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancerJulie Tsu-Yu Wu, June Corrigan, Chloe Su, et al.
Cold Spring Harbor Molecular Case Studies|December 5, 2023
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data CommonsKyle M Hernandez, Aarti Venkat, Danne C Elbers, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancerJulie Tsu-Yu Wu, June Corrigan, Chloe Su, et al.
Pageof 7